Daniel Virnich
Chief Executive Officer · Starling Oncology, Inc.
Individual
- 2024
- May 22, 2026
- 7
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel Virnich files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jorey Chernett - $2.69M in STLN purchases and sales in the last 12 months
- Brad Hively - $2.00M in STLN purchases and sales in the last 12 months
- Mohit Kaushal - $335K in STLN purchases and sales in the last 12 months
- Yale Podnos - $276K in STLN purchases and sales in the last 12 months
- Mark L. Pacala - $200K in STLN purchases and sales in the last 12 months
- Robert Ross Carter - $879 in STLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel Virnich?
Daniel Virnich is a corporate insider, tracked as Chief Executive Officer of Starling Oncology, Inc. (STLN). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Daniel Virnich last file a Form 4?
The most recent primary Form 4 on record is dated 22 May 2026, one of 7 filings going back to 2024.
